Predicting liver cancer return after surgery
Part of Cancer, Digestive system clinical trials.
This study looks at MRI scans and tissue samples from people with colorectal cancer that has spread to the liver. The goal is to find patterns that might predict whether the cancer will come back after surgery, which could help guide future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have colorectal cancer that has spread to your liver, confirmed by a biopsy.
- You received chemotherapy before your liver surgery, and your tumor shrank or stayed the same size.
- You had a special MRI of your liver within 2 months before surgery.
- You have not had liver surgery for this same problem before, and your surgery is expected to remove all cancer.
- You do not have hepatitis B or C, and you have not had another cancer treated in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well imaging predicts the outcome of surgery for liver metastases from colorectal or breast cancer. If you are having surgery to remove liver metastases, you may be able to participate.
This study compares two different types of liver surgery for people with colorectal cancer that has spread to the liver and who have specific genetic changes or a right-sided primary tumor. You will be randomly assigned to one surgery type, and researchers will track how well you do over time to see if one approach is better.
This Phase 3 trial studies a treatment approach for people whose colorectal cancer has come back in the liver within 12 months and can be treated with local procedures. It aims to see whether the study treatment can improve outcomes compared with standard care for people with a limited number of liver tumors.
This study uses your liver MRI scans and medical information to build a tool that predicts survival after surgery for colorectal cancer that has spread to the liver. It may help doctors better understand your outlook and plan care.
This study looks at your tumor's genetic makeup and a blood test after surgery to better predict if colorectal cancer that spread to the liver might come back early. The goal is to personalize follow-up care and potentially guide additional treatments.
This study uses an AI tool to predict how liver cancer might come back after surgery. It is for people with early-stage liver cancer who are already scheduled for surgery and have recent MRI scans.
Hear when a new Colo-rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.